/
MEK Inhibitors and their potential role in relapsed NSCLC MEK Inhibitors and their potential role in relapsed NSCLC

MEK Inhibitors and their potential role in relapsed NSCLC - PowerPoint Presentation

debby-jeon
debby-jeon . @debby-jeon
Follow
469 views
Uploaded On 2016-07-01

MEK Inhibitors and their potential role in relapsed NSCLC - PPT Presentation

Ranee Mehra MD Fox Chase Cancer Center Philadelphia PA Disclosures Consulting Novartis Bristol Myers Squib Spouse is employee of GSK Acknowledgment J Weiss RasRafMEKERK12 MAP kinase ID: 385444

selumetinib docetaxel trametinib kras docetaxel selumetinib kras trametinib 2013 nsclc pfs response mutant cancer study phase abstract asco erlotinib

Share:

Link:

Embed:

Download Presentation from below link

Download Presentation The PPT/PDF document "MEK Inhibitors and their potential role ..." is the property of its rightful owner. Permission is granted to download and print the materials on this web site for personal, non-commercial use only, and to display it on your personal computer provided you do not modify the materials and that you retain all copyright notices contained in the materials. By downloading content from our website, you accept the terms of this agreement.


Presentation Transcript